Cardiac Ablation Devices - Medical Devices Pipeline Assessment, 2019

Table of Contents

• 1.1 List of Tables 5
• 1.2 List of Figures 7

2 Introduction 8

• 2.1 Cardiac Ablation Devices Overview 8

3 Products under Development 9

• 3.1 Cardiac Ablation Devices - Pipeline Products by Stage of Development 9
• 3.2 Cardiac Ablation Devices - Pipeline Products by Territory 10
• 3.3 Cardiac Ablation Devices - Pipeline Products by Regulatory Path 11
• 3.4 Cardiac Ablation Devices - Pipeline Products by Estimated Approval Date 12
• 3.5 Cardiac Ablation Devices - Ongoing Clinical Trials 13

4 Cardiac Ablation Devices - Pipeline Products under Development by Companies 14

• 4.1 Cardiac Ablation Devices Companies - Pipeline Products by Stage of Development 14
• 4.2 Cardiac Ablation Devices - Pipeline Products by Stage of Development 15

5 Cardiac Ablation Devices Companies and Product Overview 16

• 5.1 AblaCor Medical Corporation Company Overview 16
  • 5.1.1 AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 16
• 5.2 Adagio Medical Inc. Company Overview 18
  • 5.2.1 Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
• 5.3 AFreeze GmbH Company Overview 21
  • 5.3.1 AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview 21
• 5.4 AngioDynamics Inc Company Overview 25
  • 5.4.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 25
• 5.5 Atrian Medical Ltd Company Overview 26
  • 5.5.1 Atrian Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 26
• 5.6 AtriCure Inc Company Overview 27
  • 5.6.1 AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview 27
• 5.7 Baylis Medical Company Inc Company Overview 32
  • 5.7.1 Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview 32
• 5.8 Corfigo Inc Company Overview 33
  • 5.8.1 Corfigo Inc Pipeline Products & Ongoing Clinical Trials Overview 33
• 5.9 Coridea, LLC Company Overview 34
  • 5.9.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview 34
• 5.10 CPSI Biotech Company Overview 35
  • 5.10.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 35
• 5.11 Helical Solutions, Inc. (Inactive) Company Overview 39
  • 5.11.1 Helical Solutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 39
• 5.12 Johns Hopkins University Company Overview 40
  • 5.12.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 40
• 5.13 Kardium Inc Company Overview 42
  • 5.13.1 Kardium Inc Pipeline Products & Ongoing Clinical Trials Overview 42
• 5.14 LuxCath, LLC Company Overview 43
  • 5.14.1 LuxCath, LLC Pipeline Products & Ongoing Clinical Trials Overview 43
• 5.15 Medtronic plc Company Overview 44
  • 5.15.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 44
• 5.16 Northwestern University Company Overview 49
  • 5.16.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 49
• 5.17 Sheba Medical Center Company Overview 50
  • 5.17.1 Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 50
• 5.18 Spectranetics Corp Company Overview 51
  • 5.18.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview 51
• 5.19 Thermedical Inc Company Overview 52
  • 5.19.1 Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview 52
• 5.20 Tufts Medical Center Company Overview 55
  • 5.20.1 Tufts Medical Center Pipeline Products & Ongoing Clinical Trials Overview 55
• 5.21 University of California Los Angeles Company Overview 56
  • 5.21.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 56
• 5.22 University of Chicago Company Overview 57
  • 5.22.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 57
• 5.23 VytronUS Inc Company Overview 58
  • 5.23.1 VytronUS Inc Pipeline Products & Ongoing Clinical Trials Overview 58

6 Cardiac Ablation Devices- Recent Developments 62

• 6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 62
• 6.2 Nov 18, 2019: Biosense Webster launches a two-pronged initiative to tackle the new millennium epidemic of Atrial Fibrillation 64
• 6.3 Nov 14, 2019: Stereotaxis reports 2019 third quarter financial results 65
• 6.4 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 66
• 6.5 Nov 08, 2019: Stereotaxis and Catheter Precision combine robotic navigation and preoperative arrhythmia localization to treat cardiac arrhythmias 67

7 Appendix 112

• 7.1 Methodology 112
• 7.2 About GlobalData 115
• 7.3 Contact Us 115